Human Development Center

Human Development Center

Services:
Education and Counseling Services
• HIV or AIDS education, counseling, or support
• Substance use disorder education
• Hepatitis education, counseling, or support
• Marital/couples counseling
• Group counseling
• Family counseling
• Health education services other than HIV/AIDS or hepatitis
• Individual counseling
• Smoking/vaping/tobacco cessation counseling

License/Certification/Accreditation

• State mental health department
• State department of health
• State Substance use treatment agency

Ancillary Services

• Mental health services
• Case management service
• Suicide prevention services
• Social skills development
• Integrated primary care services

Facility Operation (e.g., Private, Public)

• Private non-profit organization

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder
• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Type of Opioid Treatment

• Accepts clients using MAT but prescribed elsewhere
• Relapse prevention with naltrexone
• Prescribes buprenorphine
• Maintenance service with medically supervised withdrawal after stabilization
• Buprenorphine maintenance
• Prescribes naltrexone

Treatment Approaches

• Relapse prevention
• 12-step facilitation
• Matrix Model
• Motivational interviewing
• Trauma-related counseling
• Telemedicine/telehealth therapy
• Brief intervention
• Cognitive behavioral therapy
• Substance use disorder counseling

Payment/Insurance/Funding Accepted

• IHS/Tribal/Urban (ITU) funds
• SAMHSA funding/block grants
• Cash or self-payment
• Private health insurance
• Medicaid
• Federal, or any government funding for substance use treatment programs
• Federal military insurance (e.g., TRICARE)
• Medicare
• State-financed health insurance plan other than Medicaid

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity
• In-network prescribing entity
• No formal relationship with prescribing entity

External Opioid Medications Source

• Other contracted prescribing entity
• No formal relationship with prescribing entity
• In-network prescribing entity

Assessment/Pre-treatment

• Interim services for clients
• Screening for substance use
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for tobacco use
• Outreach to persons in the community
• Comprehensive mental health assessment

Type of Care

• Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
• Substance use treatment

Testing

• Drug or alcohol urine screening
• Drug and alcohol oral fluid testing
• Breathalyzer or blood alcohol testing

Gender Accepted

• Female
• Male

Pharmacotherapies

• Buprenorphine (extended-release, injectable)
• Naltrexone (extended-release, injectable)
• Medication for mental disorders
• Acamprosate (Campral®)
• Buprenorphine without naloxone
• Buprenorphine with naloxone
• Naltrexone (oral)

Hospitals

• General Hospital (including VA hospital)

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Recovery Support Services

• Recovery coach
• Mentoring/peer support
• Employment counseling or training
• Housing services
• Assistance with obtaining social services

Transitional Services

• Discharge Planning
• Naloxone and overdose education
• Outcome follow-up after discharge
• Aftercare/continuing care

Age Groups Accepted

• Young Adults
• Adults

Facility Smoking Policy

• Smoking permitted in designated area

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient methadone/buprenorphine or naltrexone treatment
• Outpatient
• Intensive outpatient treatment
• Regular outpatient treatment

Special Programs/Groups Offered

• Clients with co-occurring pain and substance use disorders
• Clients with co-occurring mental and substance use disorders

Facility Vaping Policy

• Vaping permitted in designated area